C2N Diagnostics

Q: Where is C2N Diagnostics located?

C2N Diagnostics's headquarters are located at 4340 Duncan Ave, St. Louis, Missouri, 63110, United States

Q: What is C2N Diagnostics's phone number?

C2N Diagnostics's phone number is (877) 226-3424

Q: What is C2N Diagnostics's official website?

C2N Diagnostics's official website is www.c2n.com

Q: What is C2N Diagnostics's Revenue?

C2N Diagnostics's revenue is <$5 Million

Q: What is C2N Diagnostics's NAICS code?

C2N Diagnostics's NAICS: 54,541

Q: How many employees does C2N Diagnostics have?

C2N Diagnostics has 34 employees

Q: What industry does C2N Diagnostics belong to?

C2N Diagnostics is in the industry of: Medical Testing & Clinical Laboratories , Healthcare

Q: What is C2N Diagnostics competition?

C2N Diagnostics top competitors include: Eurofins Central Laboratory , Interpace Biosciences , Insight Genetics , Eutropics

Q: What technology does C2N Diagnostics use?

Some of the popular technologies that C2N Diagnostics uses are: Squarespace Online Stores, Tableau, Adobe Typekit, Sched

Q: How do I contact C2N Diagnostics?

C2N Diagnostics contact info: Phone number: (877) 226-3424 Website: www.c2n.com

Healthcare Services · Missouri, United States · 34 Employees

View Company Info for Free

About

Headquarters

4340 Duncan Ave, St. Louis, Missouri, 63110, Un...

Phone Number

(877) 226-3424

Website

www.c2n.com

Revenue

<$5 Million

Industry

Medical Testing & Clinical Laboratories

Healthcare

Most Recent Scoops

Mar 7 2024

Funding

Apr 24 2023

New Hire

C2N Diagnostics has announced that Daniel Connell has joined the organization as Head of Strategic Alliances. Previously, Connell served as Senior Director, Computational Pathology Strategy-Oncology R&D for AstraZeneca.

See all scoops

Highlights

$30M

Total Funding Amount

$15M

Most Recent Funding Amount

Number of Funding Rounds

View details

Who is C2N Diagnostics

C2N Diagnostics is a specialty diagnostics company with a vision to bring Clarity Through Innovation. C2N strives to provide exceptional laboratory services and products in the field of brain health. C2N's biomarker services and products are used for: clinical decision making to improve patient care, including diagnosis and treatment monitoring; maximizing the quality and efficiency of clinical trials that test novel treatments for neurodegeneration; and providing innovative tools to help healthcare researchers better understand novel mechanisms of disease, identify new treatment targets, and conduct important epidemiologic studies to improve global public health.Read more

Is this data correct?

View contact profiles from C2N Diagnostics

Popular SearchesC2n Diagnostics LLCC2n DiagnosticsC2nC2n LLCC2n Business Analytics LLCSIC Code 87,873NAICS Code 54,541Show more

C2N Diagnostics Org Chart

Phone

Rachel Resnick

Controller

Phone

Is C2N Diagnostics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Congratulate Masked Content for being promoted to Masked Content at C2N Diagnostics

Funding: Get notified immidiatlly once C2N Diagnostics has new funding data

C2N Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic

Check if C2N Diagnostics has recently received funding, and reach out quickly before it becomes old news!

Check out if C2N Diagnostics is spiking on competitors!

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Product Launch: Get notified when C2N Diagnostics launches new products

Earning: See what the market has to say on C2N Diagnostics recently announced quarterly report

Click to see if C2N Diagnostics had a recent Job posting/layoffs

Website visits: Recent activity has been detected on your website

Recommended Actions

Reach out to Masked Content who joined C2N Diagnostics as Masked Content

Find more new buyers

Similar Companies to C2N Diagnostics

Analyze insights from companies similar to C2N Diagnostics and make strategic comparisons based on performance, financial data, growth and unique benchmarks.

See more companies

View Email Formats for C2N Diagnostics

C2N Diagnostics financials insights

Gather financial insights about C2N Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

Graph showing recent funding, most recent acquisition, and main investor information for C2N Diagnostics.

See All Financials Insights

C2N Diagnostics Employee Growth Rate

Graph showing projected employee growth data for C2N Diagnostics

View C2N Diagnostics’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

C2N Diagnostics Tech Stack

A closer look at the technologies used by C2N Diagnostics

Squarespace Online Stores

See more technologies

Most Recent Scoops

Mar 7 2024

Funding

Jun 13 2023

Left Company

Executive Move

Apr 24 2023

New Hire

Apr 24 2023

New Hire

Executive Move

C2N Diagnostics has announced that Ozgur Sensoy has joined the organization as Senior VP, Commercial Operations. Previously, Sensoy served as Head of US Rare Disease Genetics for Quest Diagnostics.

Executive Moves, New Hire

Feb 16 2023

Funding

, a brain health diagnostics company, has recently secured $15 million in Grant funding from GHR Foundation.

See more scoops

C2N Diagnostics News & Media

C2N Diagnostics Receives $15 Million Program Related Investment from GHR Foundation to Develop Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease
ST. LOUIS--(BUSINESS WIRE)-- #Alzheimers--C2N Diagnostics, LLC (C2N), a world leader in developing Alzheimer’s disease-specific fluid biomarker tests, has received a new $15 million program-related investment from GHR Foundation (GHR) to support the next generation of tests specific to tau tangle pathology. Tau tangles represent an integral component of Alzheimer’s disease pathology and are believed to play an important role in clinical progression of the disease. This next generation of tests o
Sep 30, 2024
www.businesswire.com
C2N Receives Funding from Diagnostics Accelerator to Develop a Decentralized Clinical Mass Spectrometry Solution to Enable High-Performance Alzheimer’s Disease Testing Worldwide
ST. LOUIS--(BUSINESS WIRE)-- #Alzheimers--C2N Diagnostics, LLC, an international leader with its Precivity blood tests to help diagnose Alzheimer’s disease, aims to create a fully automated, standardized, high resolution liquid chromatography-mass spectrometry (LC-MS) platform to enable the local deployment of the precise innovation at the core of its clinical and research biomarkers in clinical labs around the world. C2N has received a groundbreaking investment up to $7.025 million from the Alz
Sep 25, 2024
www.businesswire.com
Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Invests More Than $7 Million in C2N Diagnostics' Blood Tests
New investment supports DxA's mission to advance the development of scalable and universally accessible diagnostics. Blood tests will be key to further evolving Alzheimer's diagnostics, care, and research. NEW YORK, Sept. 25, 2024 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation...
Sep 25, 2024
www.prnewswire.com
C2N Diagnostics and Unilabs Announce Global Partnership, Bringing Together Innovation Leaders in Diagnostics and Laboratory Medicine to Advance Brain Health
ST. LOUIS & GENEVA, Switzerland--(BUSINESS WIRE)-- #Alzheimers--Unilabs (“Unilabs”), a leading international provider of diagnostic services, and C2N Diagnostics, LLC (“C2N”), a pioneer in advanced diagnostic solutions in the field of Alzheimer’s disease (AD) and related neurological disorders, today announced a major milestone in brain health diagnostics and research across Europe and beyond. Unilabs and C2N have signed a multi-year partnership agreement that will increase access to C2N’s Preci
Aug 7, 2024
www.businesswire.com
JAMA Publishes Landmark Clinical Study Showing C2N Diagnostics’ PrecivityAD2™ Blood Test Markedly Improves Accuracy of AD Diagnosis in Both Primary Care and Specialized Memory Care
ST. LOUIS--(BUSINESS WIRE)-- #AAIC2024--The Journal of the American Medical Association (JAMA) has published a large clinical study examining the ability of C2N Diagnostics, LLC’s (C2N) PrecivityAD2™ blood test to improve the diagnostic accuracy of Alzheimer’s disease (AD) in primary care settings, where most patients with cognitive concerns turn to for initial answers about their memory loss. The study found similar robustness for the PrecivityAD2 test in patients who saw memory care specialist
Jul 28, 2024
www.businesswire.com

Top Companies in United States

Frequently Asked Questions Regarding C2N Diagnostics

Where is C2N Diagnostics located?

C2N Diagnostics's headquarters are located at 4340 Duncan Ave, St. Louis, Missouri, 63110, United States

What is C2N Diagnostics's phone number?

C2N Diagnostics's phone number is (877) 226-3424

What is C2N Diagnostics's official website?

C2N Diagnostics's official website is www.c2n.com

What is C2N Diagnostics's Revenue?

C2N Diagnostics's revenue is <$5 Million

What is C2N Diagnostics's SIC code?

C2N Diagnostics's SIC: 87,873

What is C2N Diagnostics's NAICS code?

C2N Diagnostics's NAICS: 54,541

How many employees does C2N Diagnostics have?

C2N Diagnostics has 34 employees

What industry does C2N Diagnostics belong to?

C2N Diagnostics is in the industry of: Medical Testing & Clinical Laboratories, Healthcare

What is C2N Diagnostics competition?

C2N Diagnostics top competitors include: Eurofins Central Laboratory, Interpace Biosciences, Insight Genetics, Eutropics

What technology does C2N Diagnostics use?

Some of the popular technologies that C2N Diagnostics uses are: Squarespace Online Stores, Tableau, Adobe Typekit, Sched

How do I contact C2N Diagnostics?

C2N Diagnostics contact info: Phone number: (877) 226-3424 Website: www.c2n.com

What does C2N Diagnostics do?

What are C2N Diagnostics social media links?

C2N Diagnostics Linkedin page C2N Diagnostics Twitter page C2N Diagnostics Facebook page

How much funding has C2N Diagnostics raised to date?

C2N Diagnostics has raised $30 Million in 2 funding rounds

When was the last funding round for C2N Diagnostics?

C2N Diagnostics closed its last funding round on Mar 06, 2024 with the amount of $15 Million

Who invested in C2N Diagnostics?

C2N Diagnostics has 2 investors including us.eisai.com and GHR Foundation.

Is C2N Diagnostics a public company?

C2N Diagnostics is private company therefore does not currently have an official ticker symbol

See more information about C2N Diagnostics

C2N Diagnostics Latest Hires and Their Positions

C2N Diagnostics is expanding and recently hired new employees. Here are the latest additions to the team.

Garrett McSweeney

Manager, Marketing

Joined Aug 1, 2024

Phone

Nikola Kasarov

Joined Jul 26, 2024

Phone

Sudarshana Erky

Joined Jul 10, 2024

Phone

Kyung Kim

Data Analyst

Joined Jul 1, 2024

Phone

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.